Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Catch the moon dancing with bright star Regulus tonight - 2Netanyahu on Gush Etzion terror attack: 'We will complete war on all fronts'
- 3Interstellar comet 3I/ATLAS to pass closest to Earth on Friday
- 4UNICEF: More than 100 children killed in Gaza since ceasefire
- 56 Well known Ladies' Fragrances On the planet
- The most effective method to Distinguish the Best Material Organization in Your Space
- What's the new 'Knives Out' mystery about? Everything to know about 'Wake Up Dead Man,' including who's in the cast and what the reviews say.
- Electric Vehicles for Eco-Accommodating Driving
- West Antarctica’s history of rapid melting foretells sudden shifts in continent’s ‘catastrophic’ geology
- A definitive Manual for the Over-Ear Earphones
- Relish the World: Notable Caf\u00e9s You Really want to Attempt
- Beating Wellbeing Difficulties: Individual Victories in Health
- Beneficial Growing Conditions in West Africa Weigh on Cocoa Prices
- Vote in favor of Your Number one kind of pie
